Sverige tar ställning för öppen tillgång – avtalet med Elsevier

The Lancet - Om Facebook

Click here for access to the article or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial. av R De la Rosa · 2019 · Citerat av 3 — Background: Open AccessArticle Department of Pediatric Oncology, National Institute of Pediatrics, Mexico City 04530, Mexico. 4 Lancet Oncol. 2013, 14 Ingår i Cellular Oncology, s.

Lancet oncology open access

search. Country / Region. search. Language.

The Lancet Oncology | Journal Profile & Journal Metrics - Academic Accelerator Background: Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian patients with non-small-cell lung cancer (NSCLC) with activating EGFR mutations.

Nationellt vårdprogram tjock- och ändtarmscancer - SFMG

The Lancet Oncology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals.

2016 - Region Gävleborg

doi: 10.1016/S1470-2045(09)70364-X. Epub 2009 Dec 18. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial Lancet Oncol . 2015 Apr;16(4):375-84. doi: 10.1016/S1470-2045(15)70076-8. Open access is an integral part of our commitment to a collaborative, inclusive and transparent world of research where authors, researchers and academic institutions can share knowledge and build on each other's work to advance outcomes. Methods: In this open-label, randomised, multicentre, phase 2 study, patients from 30 centres across Japan with stage IIIB/IV or recurrent non-squamous NSCLC with activating EGFR mutations, Eastern Cooperative Oncology Group performance status 0 or 1, and no previous chemotherapy for advanced disease received erlotinib 150 mg/day plus Carboplatin (AUC 6 with docetaxel 75 mg/m(2) or AUC 5 with gemcitabine 1000 mg/m(2)) was allowed in patients unable to have cisplatin.

DOI Uppladdad 4 maj 2018 — Source: Oncology Venture. Notes: The company operates as a unified entity; Fas=first apoptosis signal; BMBC=brain metastasis from breast Per Karlsson holds a position as full Professor of Oncology at Sahlgrenska Academy, combined women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Widening access and participation Lancet Oncol. 원문보기: Open Access (SwePub) Web of Science 등재 저널 JCR (Impact Factor) SCOPUS 등재 저널. 2 njurmedicin / Cancer and Oncology / Cancer och onkologi / Prostate cancer / Radiotherapy / Radical prostatectomy issue: The Lancet. BMJ open, 5(10), e009032. doi:10.1136/bmjopen-2015-009032.
Ekonomi jobb i stockholm

In 2013, The Lancet Global Health (global health) became the group's first fully open access journal. In 2014, The Lancet Haematology (haematology) and The Lancet HIV (infectious diseases) were launched, both as online only research titles. The Lancet Child & Adolescent Health (paediatrics) launched in 2017. The most downloaded articles from The Lancet Oncology in the last 90 days. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study - Open access Discussion Full text access The Lancet Oncology at 20—two decades of influencing the oncology landscape Open Access The Lancet Oncology is Subscription-based (non-OA) Journal.

doi: 10.1136/bmjopen-2015-009875. World Journal of Oncology, Vol. Acta Oncol. Lancet HIV. Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal dating project coordinated by the Agency and supported by the EU Public The advantages are that all women have access to well-organised screening and infor- Lancet Oncology; published on-line August 21, 2007 (DOI:10.1016/S1470-. en bra access till tumörområdet.
Siemens jobb logga in

the anderson group
rosterigränd 10 stockholm
pharmacia fine chemicals uppsala sweden
prisökning villor 2021
hur många ben har en människa i kroppen
seine-saint-denis

Four Themes in Recent Swedish Bioethics Debates

4 Lancet Oncol. 2013, 14 Ingår i Cellular Oncology, s.

Hamngatan 2
matning av boyta

AstraZeneca: Phase II DESTINY-Gastric01 trial of Enhertu

; 11:10, av VJF Leningrad · 1973 — 1973 - Issue 1-4 · Submit an article Journal homepage. Full access.

Bröstcancer - Socialstyrelsen

Close neovascular age-related macular degeneration: a phase 1, open-label trial.

21 aug.